Metzger Michael A

Syndax Pharmaceuticals, Inc. ยท Chief Executive Officer

Metzger Michael A is listed in public filings as director, officer: Chief Executive Officer. This Metzger Michael A insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Syndax Pharmaceuticals, Inc. (SNDX), and Pyxis Oncology, Inc. (PYXS). Investors use Metzger Michael A's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Syndax Pharmaceuticals, Inc.SNDX$9.2M484.8k sharesSellJun 1, 2026$130.0K6.8k shares$18.99--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Pyxis Oncology, Inc.PYXS$62k45.9k sharesGrant / ExerciseMar 24, 2026$62.4K45.9k shares$1.36--
Syndax Pharmaceuticals, Inc.SNDX$10M491.7k sharesSellFeb 9, 2026$360.8K17.2k shares$21.03--
Syndax Pharmaceuticals, Inc.SNDX$10M508.8k sharesSellFeb 6, 2026$152.8K7.4k shares$20.62--
Syndax Pharmaceuticals, Inc.SNDX$9.0M440k sharesGrant / ExerciseFeb 4, 2026$9.0M440k shares$20.43--
Syndax Pharmaceuticals, Inc.SNDX--371.7k sharesGrant / ExerciseFeb 4, 2026Disclosure amount unavailable73k shares----
Syndax Pharmaceuticals, Inc.SNDX--516.3k sharesGrant / ExerciseFeb 4, 2026Disclosure amount unavailable144.6k shares----
Syndax Pharmaceuticals, Inc.SNDX$4.9M298.7k sharesSellSep 8, 2025$2.6M157.3k shares$16.41--
Syndax Pharmaceuticals, Inc.SNDX$0157.3k sharesGrant / ExerciseSep 8, 2025$1.7M157.3k shares$10.90--
Syndax Pharmaceuticals, Inc.SNDX$2.8M298.7k sharesSellJul 16, 2025$70.0K7.5k shares$9.29--
Pyxis Oncology, Inc.PYXS$36k37k sharesGrant / ExerciseMar 31, 2025$36.2K37k shares$0.98--
Syndax Pharmaceuticals, Inc.SNDX$06.1k sharesGrant / ExerciseMar 14, 2025$43.7K6.1k shares$7.20--
Syndax Pharmaceuticals, Inc.SNDX$4.5M300.1k sharesSellMar 4, 2025$117.6K7.8k shares$15.05--
Syndax Pharmaceuticals, Inc.SNDX$07.8k sharesGrant / ExerciseMar 4, 2025$56.3K7.8k shares$7.20--
Syndax Pharmaceuticals, Inc.SNDX$4.7M300.1k sharesSellFeb 10, 2025$206.0K13.3k shares$15.50--
Syndax Pharmaceuticals, Inc.SNDX$5.3M364k sharesGrant / ExerciseFeb 5, 2025$5.3M364k shares$14.65--
Syndax Pharmaceuticals, Inc.SNDX--224.4k sharesGrant / ExerciseFeb 5, 2025Disclosure amount unavailable60.5k shares----
Syndax Pharmaceuticals, Inc.SNDX--313.4k sharesGrant / ExerciseFeb 5, 2025Disclosure amount unavailable89k shares----
Pyxis Oncology, Inc.PYXS$281k70.7k sharesGrant / ExerciseJun 10, 2024$280.6K70.7k shares$3.97--